Skip to main content
Clinical Trials/NCT00938483
NCT00938483
Completed
Not Applicable

A Multicenter, Single-blind, Randomized, Phase II Study of the Tolerability and Safety of NPS-202 in Infants With Clinically Diagnosed Cow's Milk Allergy

Perrigo Nutritionals0 sites108 target enrollmentAugust 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Milk Hypersensitivity
Sponsor
Perrigo Nutritionals
Enrollment
108
Primary Endpoint
Infant reactivity to an extensively hydrolyzed infant formula
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
January 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • clinically diagnosed CMA
  • \</= 12 weeks at time of study entry
  • full-term infant
  • must be willing to use provided formula as sole source of nutrition
  • other than CMA, infant must be otherwise healthy

Exclusion Criteria

  • underlying or confounding gastrointestinal abnormalities
  • infants born from an addictive situation, HIV positive
  • if parent/guardian is considered likely to be non-compliant with the protocol requirements

Outcomes

Primary Outcomes

Infant reactivity to an extensively hydrolyzed infant formula

Time Frame: 29 days

Similar Trials